Turmeric and Curcumin for Cortisol: What the Evidence Actually Shows
September 4, 2026 · 3 min read
Turmeric has gone from curry spice to wellness staple, and curcumin, the compound responsible for turmeric's color and most of its studied activity, now gets marketed specifically as a cortisol-lowering supplement, sold in "golden milk" mixes, capsules, and stress-relief shots. Curcumin's anti-inflammatory reputation is genuinely well-earned in the research literature. Whether that translates into a reliable drop in cortisol for someone taking it is a separate question, and the evidence there is considerably thinner.
The biological argument is reasonable on its face. Chronic stress and elevated cortisol are associated with low-grade systemic inflammation, and curcumin is one of the more consistently studied natural anti-inflammatory compounds, with a large body of research, much of it in cell and animal models, showing it can influence inflammatory signaling pathways. That is a plausible reason curcumin could indirectly affect the stress response, but a mechanistic case is not the same as proof that a capsule measurably lowers cortisol in a person.
Animal research does show a direct effect, under controlled conditions. A 2010 study in Domestic Animal Endocrinology found that curcumin supplementation attenuated the rise in serum cortisol that pigs experienced during transport stress, along with changes in hippocampal nitric oxide production and BDNF expression, a protein tied to stress resilience. That is a real, physiologically specific finding, but it is a livestock study using a defined acute stressor, and effects in pigs under transport stress do not automatically carry over to humans dealing with everyday psychological stress.
Human trials tell a more mixed story. A study in the Journal of the International Society of Sports Nutrition gave curcumin to recreational athletes around two hours of endurance cycling and measured cortisol alongside inflammatory markers like interleukin-6; the differences between the curcumin and placebo groups did not reach statistical significance. A separate randomized, placebo-controlled trial in people with major depressive disorder, published in European Neuropsychopharmacology, looked at cortisol and aldosterone as exploratory biomarkers and found that placebo, not curcumin, was associated with a reduction in those hormones over the study period, the opposite direction from what curcumin marketing would predict.
That gap is the clearest way to separate what is proven from what is trend here. Reasonably well supported: curcumin has documented anti-inflammatory and antioxidant activity, and it has shown antidepressant-adjacent effects in some clinical trials for major depression, an important and separate line of research from the cortisol claim. Considerably weaker: the specific, increasingly common marketing claim that turmeric or curcumin supplements measurably lower cortisol in generally healthy people. The controlled human data that exists on that exact question is small, mixed, and in at least one trial ran in the opposite direction of the claim.
None of this makes turmeric or curcumin a bad choice. It is a food-based spice with an independently reasonable safety profile at normal culinary and typical supplemental doses, and there is little harm in including it in a diet or trying it as part of a broader stress-management approach. The mistake is expecting a specific, reliable cortisol-lowering effect from it, treating a golden milk latte as a hormone intervention rather than what the current evidence actually supports, which is a generally anti-inflammatory food compound with promising but unproven effects on stress hormones specifically.
Sources
- [1] Wei, S. et al., "Curcumin Attenuates the Effects of Transport Stress on Serum Cortisol Concentration, Hippocampal NO Production, and BDNF Expression in the Pig," Domestic Animal Endocrinology (2010).
- [2] Journal of the International Society of Sports Nutrition, "The Effect of Turmeric (Curcumin) Supplementation on Cytokine and Inflammatory Marker Responses Following 2 Hours of Endurance Cycling" (2015).
- [3] Lopresti, A.L. et al., "Curcumin and Major Depression: A Randomised, Double-Blind, Placebo-Controlled Trial Investigating the Potential of Peripheral Biomarkers to Predict Treatment Response and Antidepressant Mechanisms of Change," European Neuropsychopharmacology (2015).